SWA
CTSO icon

SOA Wealth Advisors’s Cytosorbents Corp CTSO Stock Holding History

SOA Wealth Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,222
Closed -$3.33K – 880
2024
Q3 		$3.33K Hold
2,222
– – ﹤0.01% 635
2024
Q2 		$1.56K Hold
2,222
– – ﹤0.01% 697
2024
Q1 		$2.11K Hold
2,222
– – ﹤0.01% 704
2023
Q4 		$2.47K Hold
2,222
– – ﹤0.01% 680
2023
Q3 		$4.18K Hold
2,222
– – ﹤0.01% 640
2023
Q2 		$7.98K Hold
2,222
– – ﹤0.01% 565
2023
Q1 		$7.49K Hold
2,222
– – ﹤0.01% 566
2022
Q4 		$3.44K Buy
2,222
+202
+10% +$300 ﹤0.01% 674
2022
Q3 		$2K Hold
2,020
– – ﹤0.01% 701
2022
Q2 		$4K Hold
2,020
– – ﹤0.01% 609
2022
Q1 		$6K Hold
2,020
– – ﹤0.01% 656
2021
Q4 		$8K Hold
2,020
– – ﹤0.01% 597
2021
Q3 		$16K Hold
2,020
– – ﹤0.01% 485
2021
Q2 		$15K Hold
2,020
– – ﹤0.01% 499
2021
Q1 		$17K Hold
2,020
– – ﹤0.01% 430
2020
Q4 		$22K Buy
+2,020
New +$16.9K 0.01% 384

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

SOA Wealth Advisors's CTSO Position: Q4 2024 in Review

SOA Wealth Advisors sold out of Cytosorbents Corp (CTSO) in Q4 2024, closing a stake of 2,222 shares — an estimated $3.33K sold.

SOA Wealth Advisors first reported a position in CTSO in Q4 2020 and held it in 16 quarters. The position peaked at $22K in Q4 2020. 51 funds tracked by Wall St. Rank hold CTSO as of Q4 2024.

  • SOA Wealth Advisors reported no remaining Cytosorbents Corp position as of Q4 2024 after selling out during the quarter.
  • SOA Wealth Advisors sold 2,222 Cytosorbents Corp shares in Q4 2024, an estimated $3.33K.
  • SOA Wealth Advisors first reported a position in Cytosorbents Corp in Q4 2020 and held it in 16 quarters.
  • SOA Wealth Advisors's Cytosorbents Corp position peaked at $22K in Q4 2020.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2024.

Based on SOA Wealth Advisors's 13F filing for Q4 2024, filed 28 Jan 2025.